| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Janus Kinase 2 | 7 | 2010 | 139 | 1.180 |
Why?
|
| Polycythemia Vera | 5 | 2008 | 41 | 0.900 |
Why?
|
| Translocation, Genetic | 3 | 2017 | 350 | 0.580 |
Why?
|
| Immunophenotyping | 3 | 2018 | 336 | 0.570 |
Why?
|
| Erythroid Precursor Cells | 4 | 2010 | 21 | 0.560 |
Why?
|
| Chloroplasts | 4 | 2000 | 8 | 0.520 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2002 | 85 | 0.520 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2010 | 617 | 0.480 |
Why?
|
| Philadelphia Chromosome | 1 | 2014 | 43 | 0.430 |
Why?
|
| Cytogenetic Analysis | 1 | 2014 | 79 | 0.430 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 849 | 0.430 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2014 | 44 | 0.430 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 53 | 0.430 |
Why?
|
| Myeloid Cells | 1 | 2014 | 115 | 0.410 |
Why?
|
| Lymphocytes | 1 | 2014 | 359 | 0.380 |
Why?
|
| Cell Lineage | 1 | 2014 | 349 | 0.380 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 156 | 0.380 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 578 | 0.370 |
Why?
|
| Apoptosis | 9 | 2019 | 1861 | 0.350 |
Why?
|
| Point Mutation | 2 | 2008 | 339 | 0.330 |
Why?
|
| Adipose Tissue, Brown | 4 | 1991 | 86 | 0.320 |
Why?
|
| Plant Proteins | 3 | 2000 | 89 | 0.310 |
Why?
|
| Pyrimidines | 3 | 2008 | 443 | 0.310 |
Why?
|
| Leukemia | 2 | 2020 | 375 | 0.310 |
Why?
|
| Signal Transduction | 5 | 2019 | 4683 | 0.300 |
Why?
|
| Flow Cytometry | 5 | 2018 | 769 | 0.300 |
Why?
|
| Alleles | 4 | 2010 | 1708 | 0.290 |
Why?
|
| Triterpenes | 2 | 2005 | 23 | 0.280 |
Why?
|
| Neoplasms, Second Primary | 2 | 2021 | 143 | 0.280 |
Why?
|
| Saponins | 4 | 2008 | 21 | 0.250 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 1788 | 0.250 |
Why?
|
| Sezary Syndrome | 2 | 2008 | 14 | 0.240 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1617 | 0.240 |
Why?
|
| Down Syndrome | 1 | 2008 | 233 | 0.240 |
Why?
|
| Cell Proliferation | 5 | 2010 | 2463 | 0.230 |
Why?
|
| Piperazines | 1 | 2007 | 272 | 0.230 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 72 | 0.220 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 19 | 0.190 |
Why?
|
| Mitochondria | 4 | 1992 | 759 | 0.190 |
Why?
|
| Enzyme Activation | 5 | 2008 | 589 | 0.180 |
Why?
|
| Lymphoma | 1 | 2005 | 330 | 0.180 |
Why?
|
| Telomere Shortening | 1 | 2021 | 35 | 0.180 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2001 | 12 | 0.170 |
Why?
|
| Glycoproteins | 2 | 2000 | 344 | 0.170 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 156 | 0.160 |
Why?
|
| Atovaquone | 1 | 2019 | 10 | 0.160 |
Why?
|
| Base Sequence | 6 | 2007 | 2783 | 0.160 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 80 | 0.160 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 15 | 0.150 |
Why?
|
| Proteins | 1 | 2005 | 1027 | 0.150 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 11 | 0.150 |
Why?
|
| Azacitidine | 1 | 2019 | 51 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 130 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 248 | 0.140 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 64 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 279 | 0.140 |
Why?
|
| Mutation, Missense | 3 | 2007 | 929 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2001 | 495 | 0.140 |
Why?
|
| Cancer Survivors | 1 | 2021 | 268 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 218 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 187 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 200 | 0.130 |
Why?
|
| Viruses | 1 | 2018 | 118 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2017 | 147 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 139 | 0.130 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 11 | 0.120 |
Why?
|
| Mutation | 5 | 2010 | 6177 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 294 | 0.120 |
Why?
|
| Graft Survival | 1 | 2018 | 466 | 0.120 |
Why?
|
| Humans | 27 | 2022 | 131680 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 646 | 0.120 |
Why?
|
| Bone Marrow | 4 | 2019 | 314 | 0.120 |
Why?
|
| Hot Temperature | 3 | 1990 | 144 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2018 | 285 | 0.120 |
Why?
|
| Age Factors | 2 | 2014 | 2872 | 0.110 |
Why?
|
| Cytochrome c Group | 2 | 1992 | 15 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2019 | 15057 | 0.110 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 3673 | 0.110 |
Why?
|
| NADPH Dehydrogenase | 2 | 2005 | 7 | 0.110 |
Why?
|
| DNA Primers | 3 | 2007 | 609 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2000 | 436 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1072 | 0.110 |
Why?
|
| Child | 9 | 2021 | 26299 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 944 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2000 | 984 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2014 | 116 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2018 | 560 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2014 | 832 | 0.100 |
Why?
|
| Cold Temperature | 2 | 1990 | 81 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2008 | 2971 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 1991 | 301 | 0.100 |
Why?
|
| Molecular Sequence Data | 4 | 2002 | 3616 | 0.100 |
Why?
|
| Infant | 6 | 2019 | 13306 | 0.090 |
Why?
|
| Erythropoietin | 3 | 2008 | 105 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 279 | 0.090 |
Why?
|
| Prognosis | 3 | 2019 | 4952 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 2017 | 557 | 0.090 |
Why?
|
| Cloning, Molecular | 4 | 2002 | 786 | 0.090 |
Why?
|
| Female | 14 | 2021 | 71186 | 0.090 |
Why?
|
| Oxidation-Reduction | 4 | 2005 | 442 | 0.090 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 199 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1078 | 0.090 |
Why?
|
| Male | 16 | 2021 | 65267 | 0.090 |
Why?
|
| Cytochromes | 1 | 1990 | 7 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2016 | 765 | 0.080 |
Why?
|
| Acclimatization | 1 | 1990 | 21 | 0.080 |
Why?
|
| Janus Kinase 3 | 1 | 2010 | 16 | 0.080 |
Why?
|
| Spiro Compounds | 1 | 2010 | 11 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2010 | 1571 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 1990 | 56 | 0.080 |
Why?
|
| Langerhans Cells | 1 | 2010 | 21 | 0.080 |
Why?
|
| Glycosylation | 2 | 2000 | 122 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2007 | 165 | 0.080 |
Why?
|
| Thyroxine | 1 | 1990 | 62 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 1990 | 103 | 0.080 |
Why?
|
| Epidermis | 1 | 2010 | 64 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 251 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2010 | 11 | 0.080 |
Why?
|
| Animals | 16 | 2022 | 34375 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 233 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1131 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2008 | 904 | 0.070 |
Why?
|
| Diploidy | 1 | 2008 | 40 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 1489 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2297 | 0.070 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2008 | 9 | 0.070 |
Why?
|
| Mice | 9 | 2022 | 18488 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2008 | 1018 | 0.070 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2007 | 12 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 102 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4516 | 0.070 |
Why?
|
| Liver | 4 | 2019 | 1799 | 0.070 |
Why?
|
| Adolescent | 5 | 2021 | 20982 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2564 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 173 | 0.070 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2005 | 26 | 0.070 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2007 | 21 | 0.070 |
Why?
|
| Imatinib Mesylate | 1 | 2007 | 47 | 0.070 |
Why?
|
| Rats | 6 | 2004 | 3460 | 0.070 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 77 | 0.070 |
Why?
|
| Granulocytes | 1 | 2007 | 69 | 0.070 |
Why?
|
| Purines | 1 | 2007 | 115 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 62 | 0.070 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2006 | 4 | 0.060 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 231 | 0.060 |
Why?
|
| Methemoglobinemia | 1 | 2006 | 9 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 86 | 0.060 |
Why?
|
| Pyrroles | 1 | 2008 | 186 | 0.060 |
Why?
|
| Benzamides | 1 | 2007 | 122 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 1810 | 0.060 |
Why?
|
| Culture Media | 1 | 2007 | 175 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 910 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2005 | 989 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2019 | 3864 | 0.060 |
Why?
|
| Cell Survival | 2 | 2019 | 854 | 0.060 |
Why?
|
| Cytokinesis | 1 | 2005 | 21 | 0.060 |
Why?
|
| Terpenes | 1 | 2005 | 32 | 0.060 |
Why?
|
| Schizosaccharomyces | 1 | 2005 | 64 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2005 | 24 | 0.060 |
Why?
|
| NAD | 2 | 2005 | 50 | 0.060 |
Why?
|
| Insulin | 1 | 1990 | 1151 | 0.060 |
Why?
|
| Exons | 1 | 2007 | 769 | 0.060 |
Why?
|
| Ubiquitins | 1 | 2005 | 39 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 1001 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 1346 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 133 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 260 | 0.050 |
Why?
|
| Autophagy | 1 | 2007 | 424 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 10104 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 677 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 566 | 0.050 |
Why?
|
| CD3 Complex | 2 | 2016 | 90 | 0.050 |
Why?
|
| Quinone Reductases | 1 | 2002 | 3 | 0.050 |
Why?
|
| Vitamin K 3 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1833 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 1745 | 0.050 |
Why?
|
| Electron Transport | 3 | 1992 | 60 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1236 | 0.050 |
Why?
|
| Cell Line | 1 | 2007 | 2605 | 0.050 |
Why?
|
| DNA, Plant | 1 | 2002 | 9 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 11 | 0.050 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2002 | 28 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 286 | 0.050 |
Why?
|
| Exodeoxyribonucleases | 1 | 2002 | 50 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 625 | 0.040 |
Why?
|
| FMN Reductase | 1 | 2001 | 7 | 0.040 |
Why?
|
| NADP | 1 | 2001 | 54 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2021 | 120 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 202 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1356 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 739 | 0.040 |
Why?
|
| Abdomen | 1 | 2001 | 133 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 246 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 17667 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 40 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2022 | 220 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 87 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 1397 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 50 | 0.040 |
Why?
|
| Luciferases | 1 | 2000 | 127 | 0.040 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2000 | 62 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 1990 | 117 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1958 | 0.040 |
Why?
|
| DNA Replication | 1 | 2002 | 359 | 0.040 |
Why?
|
| Arabinose | 1 | 1999 | 24 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 300 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1999 | 41 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5297 | 0.040 |
Why?
|
| Light | 1 | 2000 | 174 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2010 | 46 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1999 | 297 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2357 | 0.040 |
Why?
|
| Plant Leaves | 1 | 1999 | 55 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 294 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 77 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3454 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2010 | 127 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 1999 | 200 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 173 | 0.040 |
Why?
|
| Biological Transport | 1 | 1999 | 333 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2007 | 2568 | 0.040 |
Why?
|
| Protein Precursors | 1 | 1999 | 147 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 323 | 0.040 |
Why?
|
| Uganda | 1 | 2018 | 94 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2005 | 4769 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 309 | 0.040 |
Why?
|
| Species Specificity | 1 | 1999 | 519 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1999 | 400 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 328 | 0.040 |
Why?
|
| Triglycerides | 1 | 2001 | 605 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2022 | 777 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1122 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2017 | 136 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1517 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1999 | 435 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4696 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 376 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 580 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 364 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2001 | 1104 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2017 | 129 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 406 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2018 | 234 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 1218 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 44 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 48 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 650 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1989 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 482 | 0.030 |
Why?
|
| Kidney | 2 | 2001 | 1309 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 182 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 329 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 266 | 0.030 |
Why?
|
| Virus Replication | 1 | 2018 | 597 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 174 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 1041 | 0.030 |
Why?
|
| Mitochondria, Liver | 2 | 1992 | 36 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 667 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1252 | 0.030 |
Why?
|
| Adult | 4 | 2021 | 31719 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 2437 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 901 | 0.020 |
Why?
|
| Ubiquinone | 1 | 1992 | 27 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 1992 | 96 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 551 | 0.020 |
Why?
|
| Models, Biological | 3 | 1992 | 1392 | 0.020 |
Why?
|
| Glycerophosphates | 1 | 1991 | 4 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1991 | 23 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1991 | 41 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4050 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 1991 | 43 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 63 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2010 | 26 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2010 | 25 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 1990 | 93 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1348 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 64 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 111 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 69 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 113 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 1263 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1990 | 261 | 0.020 |
Why?
|
| Receptors, Erythropoietin | 1 | 2008 | 13 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1202 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 32 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 43 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 67 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 418 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 191 | 0.020 |
Why?
|
| Fusion Regulatory Protein 1, Heavy Chain | 1 | 2007 | 4 | 0.020 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Beclin-1 | 1 | 2007 | 32 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 31 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6494 | 0.020 |
Why?
|
| Kinetics | 2 | 2004 | 1101 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 362 | 0.020 |
Why?
|
| DNA Probes | 1 | 2007 | 120 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 171 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2006 | 147 | 0.020 |
Why?
|
| Piperidines | 1 | 2008 | 232 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 659 | 0.020 |
Why?
|
| India | 1 | 2006 | 245 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 28889 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2007 | 173 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3130 | 0.010 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2005 | 18 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2008 | 598 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 567 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 231 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2005 | 25 | 0.010 |
Why?
|
| Drug Resistance, Fungal | 1 | 2005 | 29 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2005 | 67 | 0.010 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2005 | 35 | 0.010 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2005 | 10 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1992 | 743 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 665 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 59 | 0.010 |
Why?
|
| Inactivation, Metabolic | 1 | 2005 | 26 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 496 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 750 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 74 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 129 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 489 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1626 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2004 | 97 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2004 | 13 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 835 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 48 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10959 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 145 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 198 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 189 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 960 | 0.010 |
Why?
|
| Skin | 1 | 2005 | 553 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1712 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1151 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2655 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1316 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 3405 | 0.010 |
Why?
|
| Fertility | 1 | 2002 | 266 | 0.010 |
Why?
|
| Calnexin | 1 | 1999 | 12 | 0.010 |
Why?
|
| Microsomes | 1 | 1999 | 37 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1613 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 633 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 209 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 630 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 824 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6279 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 356 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 40 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 137 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 314 | 0.010 |
Why?
|
| Antibodies | 1 | 1996 | 357 | 0.010 |
Why?
|
| Gene Expression | 1 | 1999 | 1502 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 998 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 1387 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 1992 | 32 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1992 | 88 | 0.010 |
Why?
|
| Cytosol | 1 | 1992 | 140 | 0.010 |
Why?
|
| Feedback | 1 | 1992 | 149 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 1442 | 0.010 |
Why?
|
| Reference Values | 1 | 1992 | 692 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1992 | 810 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 21261 | 0.000 |
Why?
|
| Cholesterol | 1 | 1992 | 541 | 0.000 |
Why?
|